https://orcid.org/0000-0001-7620-3267
References
- Strålin K, Wahlström E, Walther S, et al. Mortality in hospitalized COVID-19 patients was associated with the COVID-19 admission rate during the first year of the pandemic in Sweden. Infect Dis. 2021;1–7. DOI:https://doi.org/10.1080/23744235.2021.1983643
- Galloway JB, Norton S, Barker RD, et al. A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study. J Infect. 2020;81(2):282–288.
- Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score. BMJ. 2020;370:m3339.
- Shi S, Liu X, Xiao J, et al. Prediction of adverse clinical outcomes in patients with coronavirus disease 2019. J Clin Lab Anal. 2021;35(1):e23598.
- Alfaro-Martínez J-J, Calvo Mayo J, Molina Cifuentes M, et al. Generation and validation of in-hospital mortality prediction score in COVID-19 patients: Alba-score. Curr Med Res Opin. 2021;37(5):719–726.
- Stebbing J, Sánchez Nievas G, Falcone M, et al. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021;7(1):eabe4724.
- Rodriguez-Garcia JL, Sanchez-Nievas G, Arevalo-Serrano J, et al. Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study. Rheumatology. 2021;60(1):399–407.